Estimate Recalculated Feb 5, 2026 09:39PM EST
FMR LLC has an estimated net worth of $1.49 Million. This is based on reported shares across multiple companies, which include , GENERAC HOLDINGS INC., TETRAPHASE PHARMACEUTICALS INC, GT Advanced Technologies Inc., REGENXBIO Inc., Caribou Biosciences, Inc., Aclaris Therapeutics, Inc., ViewRay, Inc., Toast, Inc., Blueprint Medicines Corp, Verve Therapeutics, Inc., Unum Therapeutics Inc., Mersana Therapeutics, Inc., Coherus BioSciences, Inc., Rallybio Corp, Ultragenyx Pharmaceutical Inc., Denali Therapeutics Inc., IRONWOOD PHARMACEUTICALS INC, Flywire Corp, Beam Therapeutics Inc., INSMED Inc, Menlo Therapeutics Inc., Surface Oncology, Inc., Xilio Therapeutics, Inc., Dimension Therapeutics, Inc., PRECISION BIOSCIENCES INC, PROTEOSTASIS THERAPEUTICS, INC., Orchard Therapeutics plc, Structure Therapeutics Inc., EXA CORP, Prime Medicine, Inc., Tropicana Las Vegas Hotel & Casino, Inc., XOOM Corp, ASIAINFO-LINKAGE, INC, ARCHIPELAGO HOLDINGS INC, Neumora Therapeutics, Inc., Turnstone Biologics Corp., Fidelity Multi-Strategy Credit Fund, and Sana Biotechnology, Inc..
FMR LLC's CIK is 0000315066
2012 was FMR LLC's most active year for acquiring shares with 1 total transactions. FMR LLC's most active month to acquire stocks was the month of June. 2012 was FMR LLC's most active year for disposing of shares, totalling 3 transactions. FMR LLC's most active month to dispose stocks was the month of June. 2012 saw FMR LLC paying a total of $0.00 for 160,086 shares, this is the most they've acquired in one year. In 2012 FMR LLC cashed out on 1,200,653 shares for a total of $1,488,799.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!